A not for profit organisation

Request an appointment

Benefits of a Laser Chorioretinal Anastomosis Plus Ranibizumab vs Ranibizumab Alone for Central Retinal Vein Occlusion: 4-Year Results

Home Research Research Publication Benefits of a Laser Chorioretinal Anastomosis Plus Ranibizumab vs Ranibizumab Alone for Central Retinal Vein Occlusion: 4-Year Results

Benefits of a Laser Chorioretinal Anastomosis Plus Ranibizumab vs Ranibizumab Alone for Central Retinal Vein Occlusion: 4-Year Results.

McAllister IL, Smithies LA, Chen FK, Mackey DA, Sanfilippo PG.

Am J Ophthalmol. 2023 Aug;252:101-110. doi: 10.1016/j.ajo.2023.03.034. Epub 2023 Apr 7.

PMID: 37030494 Clinical Trial.

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Phone
(08) 9381 0777
Email
carecentre@lei.org.au

Request an appointment